Literature DB >> 27219275

Corticosteroids Are Essential for Maintaining Cardiovascular Function in Male Mice.

Diana Cruz-Topete1, Page H Myers1, Julie F Foley1, Monte S Willis1, John A Cidlowski1.   

Abstract

Activation of the hypothalamic-pituitary-adrenal axis results in the release of hormones from the adrenal glands, including glucocorticoids and mineralocorticoids. The physiological association between corticosteroids and cardiac disease is becoming increasingly recognized; however, the mechanisms underlying this association are not well understood. To determine the biological effects of corticosteroids on the heart, we investigated the impact of adrenalectomy in C57BL/6 male mice. Animals were adrenalectomized (ADX) at 1 month of age and maintained for 3-6 months after surgery to evaluate the effects of long-term adrenalectomy on cardiac function. Morphological evaluation suggested that ADX mice showed significantly enlarged hearts compared with age-matched intact controls. These changes in morphology correlated with deficits in left ventricular (LV) function and electrocardiogram (ECG) abnormalities in ADX mice. Correlating with these functional defects, gene expression analysis of ADX hearts revealed aberrant expression of a large cohort of genes associated with cardiac hypertrophy and arrhythmia. Combined corticosterone and aldosterone replacement treatment prevented the emergence of cardiac abnormalities in ADX mice, whereas corticosterone replacement prevented the effects of adrenalectomy on LV function but did not block the emergence of ECG alterations. Aldosterone replacement did not preserve the LV function but prevented ECG abnormalities. Together, the data indicate that adrenal glucocorticoids and mineralocorticoids either directly or indirectly have selective effects in the heart and their signaling pathways are essential in maintaining normal cardiac function.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27219275      PMCID: PMC4929548          DOI: 10.1210/en.2015-1604

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  38 in total

Review 1.  Glucocorticoid receptor signaling in health and disease.

Authors:  Mahita Kadmiel; John A Cidlowski
Journal:  Trends Pharmacol Sci       Date:  2013-08-14       Impact factor: 14.819

2.  A crisis of the heart: an acute reversible cardiomyopathy bridged to recovery in a patient with Addison's disease.

Authors:  Arun Krishnamoorthy; Robert J Mentz; Kristen A Hyland; Edward B McMillan; Chetan B Patel; Carmelo A Milano; Adrian F Hernandez
Journal:  ASAIO J       Date:  2013 Nov-Dec       Impact factor: 2.872

Review 3.  Glucocorticoid signaling in the heart: A cardiomyocyte perspective.

Authors:  Robert H Oakley; John A Cidlowski
Journal:  J Steroid Biochem Mol Biol       Date:  2015-03-21       Impact factor: 4.292

Review 4.  Aldosterone, mineralocorticoid receptor, and heart failure.

Authors:  Smail Messaoudi; Feriel Azibani; Claude Delcayre; Frederic Jaisser
Journal:  Mol Cell Endocrinol       Date:  2011-07-18       Impact factor: 4.102

5.  Conditional glucocorticoid receptor expression in the heart induces atrio-ventricular block.

Authors:  Yannis Sainte-Marie; Aurelie Nguyen Dinh Cat; Romain Perrier; Laurence Mangin; Christelle Soukaseum; Michel Peuchmaur; François Tronche; Nicolette Farman; Brigitte Escoubet; Jean-Pierre Benitah; Frederic Jaisser
Journal:  FASEB J       Date:  2007-05-21       Impact factor: 5.191

6.  Cardiac arrest secondary to Addison's disease.

Authors:  J J Krug
Journal:  Ann Emerg Med       Date:  1986-06       Impact factor: 5.721

Review 7.  One hormone, two actions: anti- and pro-inflammatory effects of glucocorticoids.

Authors:  Diana Cruz-Topete; John A Cidlowski
Journal:  Neuroimmunomodulation       Date:  2014-09-12       Impact factor: 2.492

Review 8.  Mechanisms, risk factors, and management of acquired long QT syndrome: a comprehensive review.

Authors:  Eleftherios M Kallergis; Christos A Goudis; Emmanuel N Simantirakis; George E Kochiadakis; Panos E Vardas
Journal:  ScientificWorldJournal       Date:  2012-04-19

9.  Method for non-invasively recording electrocardiograms in conscious mice.

Authors:  V Chu; J M Otero; O Lopez; J P Morgan; I Amende; T G Hampton
Journal:  BMC Physiol       Date:  2001-06-25

10.  Peripheral mechanisms contributing to the glucocorticoid hypersensitivity in proopiomelanocortin null mice treated with corticosterone.

Authors:  Zoi Michailidou; Anthony P Coll; Christopher J Kenyon; Nicholas M Morton; Stephen O'Rahilly; Jonathan R Seckl; Karen E Chapman
Journal:  J Endocrinol       Date:  2007-07       Impact factor: 4.286

View more
  17 in total

1.  Individual differences in glucocorticoid regulation: Does it relate to disease risk and resilience?

Authors:  Jasmine I Caulfield; Sonia A Cavigelli
Journal:  Front Neuroendocrinol       Date:  2019-11-04       Impact factor: 8.606

2.  Cardiomyocyte glucocorticoid and mineralocorticoid receptors directly and antagonistically regulate heart disease in mice.

Authors:  Robert H Oakley; Diana Cruz-Topete; Bo He; Julie F Foley; Page H Myers; Xiaojiang Xu; Celso E Gomez-Sanchez; Pierre Chambon; Monte S Willis; John A Cidlowski
Journal:  Sci Signal       Date:  2019-04-16       Impact factor: 8.192

3.  Corticosteroid Receptors in Cardiac Health and Disease.

Authors:  Jessica R Ivy; Gillian A Gray; Megan C Holmes; Martin A Denvir; Karen E Chapman
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

4.  Corticosterone Production during Repeated Social Defeat Causes Monocyte Mobilization from the Bone Marrow, Glucocorticoid Resistance, and Neurovascular Adhesion Molecule Expression.

Authors:  Anzela Niraula; Yufen Wang; Jonathan P Godbout; John F Sheridan
Journal:  J Neurosci       Date:  2018-01-30       Impact factor: 6.167

Review 5.  Glucocorticoid Signaling in Health and Disease: Insights From Tissue-Specific GR Knockout Mice.

Authors:  Shannon Whirledge; Donald B DeFranco
Journal:  Endocrinology       Date:  2018-01-01       Impact factor: 4.736

6.  Endogenous glucocorticoids prevent gastric metaplasia by suppressing spontaneous inflammation.

Authors:  Jonathan T Busada; Sivapriya Ramamoorthy; Derek W Cain; Xiaojiang Xu; Donald N Cook; John A Cidlowski
Journal:  J Clin Invest       Date:  2019-02-18       Impact factor: 14.808

Review 7.  Getting to the heart of intracellular glucocorticoid regeneration: 11β-HSD1 in the myocardium.

Authors:  Gillian A Gray; Christopher I White; Raphael F P Castellan; Sara J McSweeney; Karen E Chapman
Journal:  J Mol Endocrinol       Date:  2016-08-23       Impact factor: 5.098

Review 8.  Hypothalamic-Pituitary-Adrenal Axis Modulation of Glucocorticoids in the Cardiovascular System.

Authors:  Natalie G Burford; Natalia A Webster; Diana Cruz-Topete
Journal:  Int J Mol Sci       Date:  2017-10-16       Impact factor: 5.923

9.  Glucocorticoid receptor alters isovolumetric contraction and restrains cardiac fibrosis.

Authors:  Rachel V Richardson; Emma J Batchen; Adrian J W Thomson; Rowan Darroch; Xinlu Pan; Eva A Rog-Zielinska; Wiktoria Wyrzykowska; Kathleen Scullion; Emad A S Al-Dujaili; Mary E Diaz; Carmel M Moran; Christopher J Kenyon; Gillian A Gray; Karen E Chapman
Journal:  J Endocrinol       Date:  2017-01-05       Impact factor: 4.286

10.  Plasma renin levels are associated with cardiac function in primary adrenal insufficiency.

Authors:  Peter Wolf; Hannes Beiglböck; Paul Fellinger; Lorenz Pfleger; Stefan Aschauer; Alois Gessl; Rodrig Marculescu; Siegfried Trattnig; Alexandra Kautzky-Willer; Anton Luger; Yvonne Winhofer; Martin Krššák; Michael Krebs
Journal:  Endocrine       Date:  2019-06-08       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.